Prognostic Factors of Patients with Spinal Chondrosarcoma: A Retrospective Analysis of 98 Consecutive Patients in a Single Center

Annals of Surgical Oncology

Volumn 21, Issue 11, 2014, Pages 3572-3578

  Yin, Huabin ^a,c   Zhou, Wang ^a   Meng, Jia ^b   Zhang, Dan ^a   Wu, Zhipeng ^a   Wang, Ting ^a   Wang, Jing ^a   Wang, Peng ^a   Shi, Xin ^b   Wu, Sujia ^b   Zhao, Jianning ^b   Xiao, Jianru ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c Department of Orthopedics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; INCADRONIC ACID; METHOTREXATE; ZOLEDRONIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE ATROPHY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE STUDY; CHONDROSARCOMA; DISEASE COURSE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPINAL CHONDROSARCOMA; SPINE CANCER; SPINE SURGERY; TOTAL EN BLOC SPONDYLECTOMY; BONE NEOPLASMS; CANCER GRADING; CLINICAL TRIAL; METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SPINAL NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHONDROSARCOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84932187536     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3745-z     Document Type: Article

References (39)

1. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13(3):320–9.
2. Yang X, Wu Z, Xiao J, et al. Chondrosarcomas of the cervical and cervicothoracic spine: surgical management and long-term clinical outcome. J Spinal Disord Tech. 2012;25(1):1–9.
3. Fletcher C, Unni KK, Mertens F. “Cartilage tumours”. In: World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p. 234–57.
4. Shives TC, McLeod RA, Unni KK, Schray MF. Chondrosarcoma of the spine. J Bone Jt Surg Am. 1989;71(8):1158–65.
5. Boriani S, De Iure F, Bandiera S, et al. Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976). 2000;25(7):804–12.
6. Camins MB, Duncan AW, Smith J, Marcove RC. Chondrosarcoma of the spine. Spine (Phila Pa 1976). 1978;3(3):202–9.
7. Schoenfeld AJ, Hornicek FJ, Pedlow FX, et al. Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center. Spine (Phila Pa 1976). 2012;37(2):119–26.
8. Katonis P, Alpantaki K, Michail K, et al. Spinal chondrosarcoma: a review. Sarcoma. 2011;2011:378957.
9. Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer. 2001;91(7):1201–12.
10. York JE, Berk RH, Fuller GN, et al. Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg. 1999;90(1 Suppl):73–8.
11. Yamazaki T, McLoughlin GS, Patel S, et al. Feasibility and safety of en bloc resection for primary spine tumors: a systematic review by the Spine Oncology Study Group. Spine (Phila Pa 1976). 2009;34(22 Suppl):S31–8.
12. Stuckey RM, Marco RA. Chondrosarcoma of the mobile spine and sacrum. Sarcoma. 2011;2011:274281.
13. Kubo T, Shimose S, Matsuo T, et al. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. J Orthop Res. 2006;24(6):1138–44.
14. Lai TJ, Hsu SF, Li TM, et al. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line. Acta Pharmacol Sin. 2007;28(8):1231–5.
15. Montella L, Addeo R, Faiola V, et al. Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports. J Exp Clin Cancer Res. 2009;28:7.
16. Streitbuerger A, Henrichs M, Ahrens H, et al. Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78. Int Orthop. 2011;35(9):1369–73.
17. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia: I. Paraplegia. 1969;7(3):179–92.
18. Unni KK, Dahlin DC. Grading of bone tumors. Semin Diagn Pathol. 1984;1(3):165–72.
19. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40(2):818–31.
20. Fletcher C, Unni KK, Mertens F. World Health Organization classification of tumors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p. 247–51.
21. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;(204):9–24.
22. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001;26(3):298–306.
23. Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine: terminology and surgical staging. Spine (Phila Pa 1976). 1997;22(9):1036–44.
24. Boriani S, Biagini R, De Iure F, et al. En bloc resections of bone tumors of the thoracolumbar spine: a preliminary report on 29 patients. Spine (Phila Pa 1976). 1996;21(16):1927–31.
25. Tomita K, Kawahara N, Baba H, et al. Total en bloc spondylectomy: a new surgical technique for primary malignant vertebral tumors. Spine (Phila Pa 1976). 1997;22(3):324–33.
26. Yin H, Zhang D, Wu Z, et al. Desmoplastic fibroma of the spine: a series of 12 cases and outcomes. Spine J. 2013. doi:10.1016/j.spinee.2013.09.042.
27. Xu W, Li X, Huang W, et al. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol. 2013;20(3):804–10.
28. Widhe B, Bauer HC; Scandinavian Sarcoma Group. Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: a population-based Scandinavian Sarcoma Group study of 106 patients. J Thorac Cardiovasc Surg. 2009;137(3):610–4.
29. Strike SA, McCarthy EF. Chondrosarcoma of the spine: a series of 16 cases and a review of the literature. Iowa Orthop J. 2011;31:154–9.
30. Rao G, Suki D, Chakrabarti I, et al. Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine. 2008;9(2):120–8.
31. Amendola L, Cappuccio M, De Iure F, et al. En bloc resections for primary spinal tumors in a 20 years of experience: effectiveness and safety. Spine J. 2014. doi:10.1016/j.spinee.2014.02.030.
32. Boriani S, Bandiera S, Donthineni R, et al. Morbidity of en bloc resections in the spine. Eur Spine J. 2010;19(2):231–41.
33. Bandiera S, Boriani S, Donthineni R, et al. Complications of en bloc resections in the spine. Orthop Clin N Am. 2009;40(1):125–31.
34. McDonnell MF, Glassman SD, Dimar II JR, et al. Perioperative complications of anterior procedures on the spine. J Bone Jt Surg Am. 1996;78(6):839–47.
35. Quiriny M, Gebhart M. Chondrosarcoma of the spine: a report of three cases and literature review. Acta Orthop Belg. 2008;74(6):885–90.
36. Fisher CG, Keynan O, Boyd MC, Dvorak MF. The surgical management of primary tumors of the spine: initial results of an ongoing prospective cohort study. Spine (Phila Pa 1976). 2005;30(16):1899–908.
37. Ozkan E, Gupta S. Embolization of spinal tumors: vascular anatomy, indications, and technique. Tech Vasc Interv Radiol. 2011;14(3):129–40.
38. Vetter SC, Strecker EP, Ackermann LW, Harms J. Preoperative embolization of cervical spine tumors. Cardiovasc Interv Radiol. 1997;20(5):343–7.
39. Giuffrida AY, Burgueno JE, Koniaris LG, et al. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Jt Surg Am. 2009;91(5):1063–72.